{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:08:11Z","timestamp":1778850491352,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.expneurol.2008.05.003","type":"journal-article","created":{"date-parts":[[2008,5,17]],"date-time":"2008-05-17T04:20:38Z","timestamp":1210998038000},"page":"538-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Altered behavioural and neurochemical profile of l-DOPA following deuterium substitutions in the molecule"],"prefix":"10.1016","volume":"212","author":[{"given":"Torun","family":"Malml\u00f6f","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torgny H.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Schilstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2008.05.003_bib1","first-page":"S60","article-title":"Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?","volume":"47","author":"Calabresi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.05.003_bib2","first-page":"1","article-title":"Deuterium isotope effects in the metabolism of drugs and xenobiotics: implication for drug design","volume":"14","author":"Foster","year":"1985","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.expneurol.2008.05.003_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1139\/y99-005","article-title":"Pharmacological uses and perspectives of heavy water and deuterated compounds","volume":"77","author":"Kushner","year":"1999","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.expneurol.2008.05.003_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(77)91146-1","article-title":"Success and problems of long-term levodopa therapy in Parkinson's disease","volume":"1","author":"Marsden","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2008.05.003_bib5","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1021\/bi00282a011","article-title":"Magnitude of intrinsic isotope effects in the dopamine b-monooxygenase reaction","volume":"22","author":"Miller","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2008.05.003_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1212\/WNL.40.2.340","article-title":"Levodopa-induced dyskinesia: review, observations, and speculations","volume":"40","author":"Nutt","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.05.003_bib7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1212\/WNL.44.5.913","article-title":"Effect of peripheral catechol-O-methyltransferase inhibition of the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients","volume":"44","author":"Nutt","year":"1994","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2008.05.003_bib8","first-page":"56","article-title":"Pulsatile stimulation of dopamine receptors and levodopa-induced motor complications in Parkinson's disease: implications for the early use of COMT inhibitors","volume":"55","author":"Olanow","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2008.05.003_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","article-title":"Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications","volume":"5","author":"Olanow","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2008.05.003_bib10","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.expneurol.2008.05.003_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/mds.10031","article-title":"Clinical-pathological study of levodopa complications","volume":"17","author":"Rajput","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2008.05.003_bib12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/mds.1143","article-title":"Idazoxan, an alpha-2 antagonist, and l-DOPA-induced dyskinesias in patients with Parkinson's disease","volume":"16","author":"Rascol","year":"2001","journal-title":"Mov. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2008.05.003_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00003495-199855001-00004","article-title":"Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial","volume":"55","author":"Rinne","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.expneurol.2008.05.003_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/mds.20317","article-title":"Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naive primates","volume":"20","author":"Smith","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2008.05.003_bib15","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/0006-2952(82)90601-3","article-title":"Deuterium isotope effect on enzymatic oxidation of dopamine and serotonin","volume":"31","author":"Yu","year":"1982","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2008.05.003_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0006-2952(86)90094-8","article-title":"Stereospecific deuterium substitution at the \u03b1-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues","volume":"35","author":"Yu","year":"1986","journal-title":"Biochem. Pharmacol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608002124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608002124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:43:25Z","timestamp":1762148605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488608002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0014488608002124"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.05.003","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered behavioural and neurochemical profile of l-DOPA following deuterium substitutions in the molecule","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}